$0.2751
-0.00160-0.58%
At close: -
$0.2625
-0.01-4.58%
After Hours: 4:51 PM EDT
Comments
Loading...
Adaptimmune Therapeutics Stock Short Interest Report | NASDAQ:ADAP | Benzinga
Short interest in Adaptimmune Therapeutics PLC (NASDAQ:ADAP) decreased during the last reporting period, falling from 5.45M to 4.59M. This put 2.57% of the company's publicly available shares short.
Short interest in Adaptimmune Therapeutics Corp (XNAS:ADAP) decreased during the last reporting period, falling from 280.30M to 275.20M. This put 1.17% of the company's publicly available shares short.
Based on the recent average volume of 2.38M shares traded per day, it would take 1.93 day(s) for holders of this short interest to close out their positions without sending the stock sharply higher.
Short Interest
4.59M
Short Interest %
2.57%
Days to Cover
1.93
| Get Alert | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| ADAP | Adaptimmune Therapeutics plc A | 04/15/2025 | 04/25/2025 | 2.57% | 178,484,267 | 4,594,643 | 2,380,151 | 1.93 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/31/2025 | 04/09/2025 | 3.17% | 172,020,174 | 5,454,233 | 3,438,008 | 1.59 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/14/2025 | 03/25/2025 | 3.28% | 172,020,174 | 5,642,793 | 1,284,948 | 4.39 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/28/2025 | 03/11/2025 | 3.73% | 170,671,440 | 6,358,415 | 1,248,348 | 5.09 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/14/2025 | 02/26/2025 | 4.21% | 170,671,440 | 7,190,442 | 598,859 | 12.01 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/31/2025 | 02/11/2025 | 4.03% | 170,671,440 | 6,878,898 | 710,873 | 9.68 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/15/2025 | 01/27/2025 | 3.38% | 170,671,440 | 5,760,733 | 1,770,944 | 3.25 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/31/2024 | 01/10/2025 | 3.22% | 170,671,440 | 5,502,013 | 3,011,918 | 1.83 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/13/2024 | 12/24/2024 | 2.97% | 170,671,440 | 5,064,481 | 2,315,237 | 2.19 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/29/2024 | 12/10/2024 | 3.94% | 170,671,440 | 6,722,267 | 2,087,286 | 3.22 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/15/2024 | 11/26/2024 | 4.05% | 170,671,440 | 6,906,004 | 2,480,987 | 2.78 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/31/2024 | 11/11/2024 | 3.14% | 170,533,678 | 5,349,350 | 1,179,368 | 4.54 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/15/2024 | 10/24/2024 | 3.26% | 170,533,678 | 5,555,099 | 1,050,793 | 5.29 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/30/2024 | 10/09/2024 | 3.57% | 170,533,678 | 6,086,908 | 1,110,220 | 5.48 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/13/2024 | 09/24/2024 | 4.11% | 170,533,678 | 7,001,127 | 895,769 | 7.82 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/30/2024 | 09/11/2024 | 4.00% | 170,533,678 | 6,825,007 | 1,372,903 | 4.97 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/15/2024 | 08/26/2024 | 4.18% | 170,533,678 | 7,130,362 | 3,178,203 | 2.24 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/31/2024 | 08/09/2024 | 4.18% | 170,350,212 | 7,127,656 | 1,745,293 | 4.08 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/15/2024 | 07/24/2024 | 3.70% | 170,350,212 | 6,298,988 | 2,005,272 | 3.14 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/28/2024 | 07/10/2024 | 3.31% | 170,350,212 | 5,641,870 | 1,610,557 | 3.5 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/14/2024 | 06/26/2024 | 2.88% | 170,350,212 | 4,903,957 | 1,623,020 | 3.02 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/31/2024 | 06/11/2024 | 2.71% | 170,350,212 | 4,621,117 | 2,449,841 | 1.89 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/15/2024 | 05/24/2024 | 2.02% | 170,350,212 | 3,441,159 | 832,969 | 4.13 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/30/2024 | 05/09/2024 | 2.06% | 170,350,212 | 3,517,477 | 1,193,320 | 2.95 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/15/2024 | 04/24/2024 | 2.00% | 170,350,212 | 3,407,756 | 1,320,412 | 2.58 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/28/2024 | 04/09/2024 | 1.88% | 170,284,046 | 3,197,059 | 1,405,327 | 2.27 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 03/15/2024 | 03/26/2024 | 2.89% | 107,581,286 | 3,112,390 | 2,408,238 | 1.29 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/29/2024 | 03/11/2024 | 2.60% | 107,581,286 | 2,800,124 | 1,606,871 | 1.74 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 02/15/2024 | 02/27/2024 | 2.72% | 107,581,286 | 2,928,624 | 2,035,389 | 1.44 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/31/2024 | 02/09/2024 | 4.38% | 107,581,286 | 4,710,050 | 2,503,674 | 1.88 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 01/12/2024 | 01/24/2024 | 5.36% | 107,581,286 | 5,765,134 | 880,263 | 6.55 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/29/2023 | 01/10/2024 | 5.30% | 107,581,286 | 5,703,578 | 1,113,538 | 5.12 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 12/15/2023 | 12/27/2023 | 5.69% | 107,581,286 | 6,123,889 | 566,587 | 10.81 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/30/2023 | 12/11/2023 | 5.74% | 107,581,286 | 6,170,818 | 469,066 | 13.16 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 11/15/2023 | 11/27/2023 | 5.57% | 107,581,286 | 5,990,432 | 338,434 | 17.7 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/31/2023 | 11/09/2023 | 5.43% | 107,581,286 | 5,846,727 | 425,152 | 13.75 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 10/13/2023 | 10/24/2023 | 6.22% | 107,581,286 | 6,694,686 | 417,253 | 16.04 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/29/2023 | 10/10/2023 | 5.54% | 107,581,286 | 5,965,238 | 389,120 | 15.33 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 09/15/2023 | 09/26/2023 | — | — | 6,045,098 | 475,525 | 12.71 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/31/2023 | 09/12/2023 | — | — | 5,870,902 | 343,004 | 17.12 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 08/15/2023 | 08/24/2023 | — | — | 5,762,250 | 543,129 | 10.61 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/31/2023 | 08/09/2023 | 3.88% | 148,060,000 | 5,739,521 | 738,229 | 7.77 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 07/14/2023 | 07/25/2023 | 3.82% | 148,060,000 | 5,656,350 | 627,561 | 9.01 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/30/2023 | 07/12/2023 | 4.08% | 146,750,000 | 5,989,046 | 1,288,092 | 4.65 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 06/15/2023 | 06/27/2023 | 5.08% | 146,750,000 | 7,449,459 | 1,238,581 | 6.01 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/31/2023 | 06/09/2023 | 6.79% | 146,750,000 | 9,959,746 | 965,543 | 10.32 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 05/15/2023 | 05/24/2023 | 6.24% | 146,750,000 | 9,156,753 | 588,369 | 15.56 | Get Alert |
| ADAP | Adaptimmune Therapeutics plc A | 04/28/2023 | 05/09/2023 | 6.16% | 145,770,000 | 8,984,102 | 911,931 | 9.85 | Get Alert |
Looking for the most shorted stocks?
